{
    "root": "3532764f-32ae-3083-e063-6394a90a111e",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Sevelamer Carbonate",
    "value": "20250515",
    "ingredients": [
        {
            "name": "AMMONIA",
            "code": "5138Q19F1X"
        },
        {
            "name": "DIACETYLATED MONOGLYCERIDES",
            "code": "5Z17386USF"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357"
        },
        {
            "name": "HYDROXYPROPYL CELLULOSE (1600000 WAMW)",
            "code": "RFW2ET671P"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3"
        },
        {
            "name": "SHELLAC",
            "code": "MB5IUD6JUA"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "ZINC STEARATE",
            "code": "H92E6QA4FV"
        },
        {
            "name": "SEVELAMER CARBONATE",
            "code": "9YCX42I8IU"
        }
    ],
    "indications": "sevelamer carbonate tablets indicated control serum phosphorus adults children 6 years age older chronic kidney disease ( ckd ) dialysis .",
    "contraindications": "• starting dose sevelamer carbonate tablets 0.8 1.6 grams administered orally three times per day meals based serum phosphorus levels adult patients based body surface area ( bsa ) category pediatric patients . ( 2.1 ) • titrate 0.8 g per meal two-week intervals adult patients needed obtain serum phosphorus target . ( 2.1 ) • titrate based bsa category pediatric patients two-week intervals 6 weeks every 4 weeks needed obtain serum phosphorus target . ( 2.1 )",
    "warningsAndPrecautions": "tablets : sevelamer carbonate tablets 800 mg supplied white white , oval shaped , biconvex , film-coated tablets imprinted “ l 28 ” one side plain side . ndc : 72162-2499-1 : 100 tablets bottle ndc : 72162-2499-2 : 270 tablets bottle ndc : 72162-2499-4 : 50 tablets bottle ndc : 72162-2499-9 : 90 tablets bottle storage : store 20° 25°c ( 68° 77°f ) : excursions permitted 15° 30°c ( 59° 86°f ) . [ usp controlled room temperature ] protect moisture . dispense tight container . repackaged/relabeled : bryant ranch prepack , inc. burbank , ca 91504",
    "adverseReactions": "sevelamer carbonate tablets contraindicated patients bowel obstruction . sevelamer carbonate tablets contraindicated patients known hypersensitivity sevelamer carbonate , sevelamer hydrochloride , excipients .",
    "indications_original": "Sevelamer carbonate tablets are indicated for the control of serum phosphorus in adults and children 6 years of age and older with chronic kidney disease (CKD) on dialysis.",
    "contraindications_original": "• Starting dose of sevelamer carbonate tablets is 0.8 or 1.6 grams administered orally three times per day with meals based on serum phosphorus levels for adult patients and based on body surface area (BSA) category for pediatric patients. ( 2.1 ) • Titrate by 0.8 g per meal in two-week intervals for adult patients as needed to obtain serum phosphorus target. ( 2.1 ) • Titrate based on BSA category for pediatric patients in two-week intervals for 6 weeks and then every 4 weeks as needed to obtain serum phosphorus target. ( 2.1 )",
    "warningsAndPrecautions_original": "Tablets: Sevelamer Carbonate Tablets 800 mg are supplied as white to off white, oval shaped, biconvex, film-coated tablets imprinted with “L 28” on one side and plain on other side.\n                  \n                  NDC: 72162-2499-1: 100 Tablets in a BOTTLE\n                  NDC: 72162-2499-2: 270 Tablets in a BOTTLE\n                  NDC: 72162-2499-4: 50 Tablets in a BOTTLE\n                  NDC: 72162-2499-9: 90 Tablets in a BOTTLE\n                  \n                  Storage: Store at 20° to 25°C (68° to 77°F): excursions permitted to 15° to 30°C (59° to 86°F).\n  \n[See USP controlled room temperature]\n \n                  Protect from moisture. Dispense in a tight container.\n                  \n                  Repackaged/Relabeled by:\n  \nBryant Ranch Prepack, Inc.\n  \nBurbank, CA 91504",
    "adverseReactions_original": "Sevelamer carbonate tablets are contraindicated in patients with bowel obstruction.\n                  Sevelamer carbonate tablets are contraindicated in patients with known hypersensitivity to sevelamer carbonate, sevelamer hydrochloride, or to any of the excipients."
}